⌘K

Login Start Free

Home/Filings/4/0000899243-22-002651

4//SEC Filing

MacBeath Gavin 4

Accession 0000899243-22-002651

CIK 0001783328other

View on SEC.gov Company Profile

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 4:26 PM ET

Size

5.4 KB

Accession

0000899243-22-002651

Insider Transaction Report

Form 4

Period: 2022-01-18

TScan Therapeutics, Inc.TCRX

DirectorChief Executive Officer

Transactions

Award
Stock Option (Right to Buy)
2022-01-18+140,000→ 140,000 total
Exercise: $4.85Exp: 2032-01-17→ Voting Common Stock (140,000 underlying)

Footnotes (1)

[F1]The shares subject to this option vest over 4 years of service following January 18, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

TScan Therapeutics, Inc.

CIK 0001783328

Entity typeother

Related Parties

1

filerCIK 0001738082

Filing Metadata

Form type: 4
Filed: Jan 19, 7:00 PM ET
Accepted: Jan 20, 4:26 PM ET
Size: 5.4 KB

View on SEC.gov